-
closely with medical oncologists, surgeons, and translational investigators to embed these efforts within ongoing clinical trials at City of Hope, enabling the development and validation of clinically
-
that drive tumor evolution, treatment resistance, and disease progression across multiple cancer types, including breast cancer, lung cancer, glioblastoma, ovarian cancer, and hematologic malignancies
-
focuses on defining disease subtypes, identifying key molecular drivers, and elucidating mechanisms of leukemogenesis, clonal evolution, immune regulation, and treatment response using functional genomics
Enter an email to receive alerts for evolution-"https:" "https:" "https:" "https:" positions